Abstract
The optimism surrounding multistakeholder research initiatives does not match the clear view of policies that are needed to exploit the potential of these collaborations. Here we propose some action items that stem from the integration between research advancements with the perspectives of patient-advocacy organizations, academia, and industry.
Original language | English |
---|---|
Pages (from-to) | 429-432 |
Number of pages | 4 |
Journal | Trends in Molecular Medicine |
Volume | 24 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 1 2018 |
Keywords
- biomedical research
- collective sustainability
- multistakeholder research initiatives
- patient-advocacy
ASJC Scopus subject areas
- Molecular Medicine
- Molecular Biology